Brenda Waning

Brenda Waning is the Chief of the Stop TB Partnership’s Global Drug Facility (GDF) – the world’s largest supplier of tuberculosis medicines and diagnostics for the public sector. Waning is a leading expert with more than 20 years of experience in promoting access to medicines in low-resource settings, with a focus on the intersection of pharmaceutical policy, market strategies, and access to medicines. She serves on several expert advisory groups across many different disease and technical areas.